HRA presses on with trial transparency despite legal challenge
This article was originally published in Scrip
Executive Summary
Just why the London-based CRO, Richmond Pharmacology, has decided to challenge the UK Health Research Authority's clinical trial transparency policies is still not clear, but it could well be that the CRO has the HRA's new requirement on trial registration in its sights.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.